Breyer Capital’s Morgan Cheatham on investing in health tech
Mario Aguilar covers technology in health care, including artificial intelligence, virtual reality, wearable devices, telehealth, and digital therapeutics.…
Employer health care costs stand in the way of reshoring American jobs
The Trump administration continues to pursue the most aggressive tariff policies since the Smoot-Hawley Tariff Act of 1930.…
Study finds GLP-1 drug cut migraine frequency by nearly half
GLP-1 drugs could treat more than just diabetes and obesity. They may also reduce migraine frequency. That is…
FDA ouster of top gene therapy official reveals internal tensions
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…